Harbin Medical University
Clinical trials sponsored by Harbin Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo aims to tackle Hard-to-Treat colorectal cancer Results expected Dec 2026 (estimated)
- Experimental Triple-Drug cocktail targets Hard-to-Treat breast cancer Results expected Dec 2026 (estimated)
- New app aims to ease stress for parents of autistic kids Results expected Jan 2027 (estimated)
-
New pill combo aims to fight stomach cancer when first treatment fails
Disease control Recruiting nowThis study tests whether taking oral paclitaxel plus fruquintinib can help people with advanced stomach or gastroesophageal junction cancer after their first treatment stops working. About 150 adults will receive either the new drug combo or standard chemotherapy chosen by their …
Sponsor: Harbin Medical University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Heart attack breakthrough: drugs may beat stents for mild blockages
Disease control Recruiting nowThis study looks at whether heart attack patients with mild artery narrowing can be treated with medication alone instead of getting a stent. About 2,000 people will be randomly assigned to either standard medication or medication plus a stent. The goal is to see if medication al…
Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New study aims to decode heart attack risks by analyzing plaque and immune cells
Knowledge-focused Recruiting nowThis study looks at different types of plaque in the arteries of people with coronary artery disease. Researchers will use special imaging to see the plaque and analyze blood cells at a detailed level. The goal is to understand how plaque features relate to immune responses and f…
Sponsor: Harbin Medical University • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:16 UTC